Please login to the form below
haematological cancer
This page shows the latest haematological cancer news and features for those working in and with pharma, biotech and healthcare.
AZ’s Calquence threatens Imbruvica with new leukaemia data
blockbuster product with sales of $3.6bn in 2018 and a target of $4.4bn this year across a broad range of haematological cancer indications.
Latest news
-
Celgene boosts haematology pipeline with $7bn Impact Bio deal
and downgraded sales estimates for its haematological cancer drugs.
-
The Harmony Alliance gathers to battle blood cancer
nd. general assembly based in Berlin, Germany last week, 120 representatives from the Innovative Medicines Initiative’s ( IMI) Harmony Alliance all gathered to discuss achievements and objectives surrounding blood cancer. ... Michel Van Speybroeck,
-
AbbVie and Roche plan Venclexta combo filings in leukaemia
Meanwhile, AbbVie is also looking at combining Venclexta with its flagship cancer drug, BTK inhibitor Imbruvica (ibrutinib) for haematological cancer, which has already hit the blockbuster mark with sales topping
-
Intriguing data with Juno's new CAR-T therapy
Suggests a long treatment effect from the biotech's JCAR017 candidate. CAR-T developer Juno Therapeutics has reported data suggesting the benefits of this type of cancer immunotherapy could extend long ... haematological cancer followed by JCAR017 - an
-
Celgene joins PD-1 race via partnership with BeiGene
The deal for the drug - which is in late-stage trials in cancer and has been tested in around 500 patients to date - gives haematological cancer specialist Celgene a bigger pipeline ... It is a great deal for BeiGene because it gives it a fast-track into
More from news
Approximately 2 fully matching, plus 31 partially matching documents found.
Latest Intelligence
-
Deal Watch September 2016
Janssen granted Tracon Pharmaceuticals the rights to develop two oncology programmes for prostate cancer and haematological malignancies. ... Adaptimmune Therapeutics entered into a collaboration with MD Anderson Cancer Center to develop specific
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- Novo Nordisk shareholder revolt reaches Europe
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
